Modified folfirinox
Showing 1 - 25 of 4,742
Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Devimistat
- Modified FOLFIRINOX
-
Ann Arbor, MichiganRogel Cancer Center
Jun 26, 2023
Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)
Recruiting
- Mucinous Ovarian Cancer
- +2 more
- Bevacizumab + modified FOLFIRINOX
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Dec 25, 2022
Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,
Active, not recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Metastatic Pancreatic Ductal Adenocarcinoma
- Eryaspase
- FOLFIRINOX
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022
Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)
Active, not recruiting
- Pancreatic Cancer
- CPI 613
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022
Pancreatic Ductal Adenocarcinoma Trial (JPI-547, modified FOLFIRINOX, Gemcitabine-nab-paclitaxel)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- JPI-547
- +2 more
- (no location specified)
Feb 16, 2022
Resectable Pancreatic Adenocarcinoma Trial in Seoul (neoadjuvant modified FOLFIRINOX)
Recruiting
- Resectable Pancreatic Adenocarcinoma
- neoadjuvant modified FOLFIRINOX
-
Seoul, Korea, Republic ofDivision of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
Sep 23, 2021
Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Stereotactic body radiotherapy (SBRT)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Sep 15, 2023
Metastatic Pancreatic Cancer Trial in Long Branch, New Brunswick (Folfirinox alternating with Gemcitabine-nab-Paclitaxel)
Recruiting
- Metastatic Pancreatic Cancer
- Folfirinox alternating with Gemcitabine-nab-Paclitaxel
-
Long Branch, New Jersey
- +1 more
Jun 8, 2021
Metastatic Pancreatic Ductal Adenocarcinoma Trial in France, Spain (CAN04, FOLFIRINOX)
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
-
Bordeaux, France
- +7 more
May 16, 2022
Pancreatic Cancer Trial in United States (MVT-5873, modified FOLFIRINOX (mFOLFIRINOX))
Recruiting
- Pancreatic Cancer
- MVT-5873
- modified FOLFIRINOX (mFOLFIRINOX)
-
Scottsdale, Arizona
- +3 more
Aug 17, 2022
Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus
Recruiting
- Borderline Resectable Pancreatic Cancer
- Locally Advanced Pancreatic Adenocarcinoma
- Nab paclitaxel plus gemcitabine
- mFOLFIRINOX
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Jan 27, 2022
Biliary Tract Cancer Trial in Busan (5-Fluorouracil, Leucovorin, Irinotecan)
Completed
- Biliary Tract Cancer
- 5-Fluorouracil
- +4 more
-
Busan, Korea, Republic ofDong-A University Hospital
Feb 2, 2021
Chemotherapy mFOLFIRINOX in Locally Advanced or Metastatic
Unknown status
- Cholangiocarcinoma of the Bile Duct
-
Shanghai, Shanghai, ChinaXinhua Hospital
Dec 30, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +5 more
-
Fairfield, Connecticut
- +8 more
Oct 31, 2022
Pancreatic Adenocarcinoma Trial (Nab paclitaxel, Gemcitabine, mFOLFIRINOX)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Nab paclitaxel
- +2 more
- (no location specified)
Apr 6, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- 6,8-bis(benzylthio)octanoic acid
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 22, 2021
Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)
Recruiting
- Neuroendocrine Carcinoma
- FOLFOXIRI Protocol
- Cisplatin injection
-
Caen, France
- +5 more
Apr 13, 2021
Pancreatic Cancer Trial in Houston (Oxaliplatin, Irinotecan, 5-FU)
Completed
- Pancreatic Cancer
- Oxaliplatin
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 24, 2020
Locally Advanced Malignant Tumor, Rectal Carcinoma Trial in France (drug, other, radiation, procedure)
Recruiting
- Locally Advanced Malignant Neoplasm
- Rectal Carcinoma
- Induction chemotherapy - modified FOLFIRINOX regimen
- +3 more
-
Besançon, Doubs, France
- +18 more
Jan 2, 2022
Pancreatic Adenocarcinoma Trial in Seoul (Preoperative modified FOLFIRINOX and postoperative gemcitabine)
Completed
- Pancreatic Adenocarcinoma
- Preoperative modified FOLFIRINOX and postoperative gemcitabine
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Nov 22, 2019